Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2000;31:2149-2156

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borsody, M. K.
Right arrow Articles by Weir, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borsody, M. K.
Right arrow Articles by Weir, B.
Related Collections
Right arrow Acute Stroke Syndromes
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Other Vascular biology

(Stroke. 2000;31:2149.)
© 2000 American Heart Association, Inc.


Original Contributions

Thrombin Reduces Cerebral Arterial Contractions Caused by Cerebrospinal Fluid From Patients With Subarachnoid Hemorrhage

Mark K. Borsody, MD, PhD; Gina M. DeGiovanni, BS; Linda S. Marton, PhD; Robert L. Macdonald, MD, PhD Bryce Weir, MD

From the Section of Neurosurgery, Department of Surgery, University of Chicago Medical Center and Pritzker School of Medicine, Chicago, Ill.

Background and Purpose—We observed that the second application of cerebrospinal fluid (CSF) from subarachnoid hemorrhage (SAH) patients onto cerebral arterial segments in vitro produces a greater contraction than does the initial application. It was hypothesized that the difference between the first and second applications of SAH CSF was due to the activity of thrombin.

Methods—Canine vertebrobasilar artery was removed under general anesthesia, cut into rings, and suspended in tissue culture baths so as to measure isometric tension. CSF was taken from patients 1 to 3 days after SAH via ventricular drains. CSF was administered in 10-5 to 10-1 dilutions. The thrombin antagonist hirudin (5 U) was administered before CSF in some experiments. The arterial tension response to pure oxyhemoglobin (10-4 to 3.2 g/dL) and thrombin (10-4 to 3.2 U/mL), administered alone or in combination, was also examined.

Results—Hirudin increased arterial tension generated on the initial application of SAH CSF but had no effect on the tension generated by the second application of the SAH CSF, suggesting that thrombin limits the tension generated by vasoconstrictive agents in the CSF. Thrombin and pure oxyhemoglobin administered together produced less tension than that generated in response to oxyhemoglobin administered alone; no additive response was observed by coadministering the 2 vasoconstrictive agents.

Conclusions—In the presence of oxyhemoglobin, thrombin acts to reduce cerebral arterial tension. This interaction between thrombin and hemoglobin may account for the observation that the second application of CSF from SAH patients onto cerebral arterial segments in vitro produces a greater contraction than does the initial application.


Key Words: hemoglobin • plasmin • subarachnoid hemorrhage • thrombin • vasospasm




This article has been cited by other articles:


Home page
StrokeHome page
Z.-D. Zhang, B. Yamini, T. Komuro, S. Ono, L. Johns, L. S. Marton, B. Weir, and R. L. Macdonald
Vasospasm in Monkeys Resolves Because of Loss of and Encasement of Subarachnoid Blood Clot
Stroke, August 1, 2001; 32(8): 1868 - 1874.
[Abstract] [Full Text] [PDF]